001459432 000__ 01653nam\a2200433\i\4500
001459432 001__ 1459432
001459432 003__ MiAaPQ
001459432 005__ 20230330003752.0
001459432 006__ m\\\\\o\\d\\\\\\\\
001459432 007__ cr\cn\nnnunnun
001459432 008__ 180511s2018\\\\enk\\\\\o\\\\\000\0\eng\d
001459432 020__ $$z9780128136874
001459432 020__ $$a9780128136881 (e-book)
001459432 035__ $$a(MiAaPQ)EBC5353696
001459432 035__ $$a(Au-PeEL)EBL5353696
001459432 035__ $$a(CaPaEBR)ebr11547909
001459432 035__ $$a(OCoLC)1031999488
001459432 040__ $$aMiAaPQ$$beng$$erda$$epn$$cMiAaPQ$$dMiAaPQ
001459432 050_4 $$aRM301.63$$b.L575 2018
001459432 0820_ $$a615.7$$223
001459432 24500 $$aLipid nanocarriers for drug targeting /$$cedited by Alexandru Mihai Grumezescu.
001459432 264_1 $$aOxford, United Kingdom ;$$aCambridge, MA :$$bWilliam Andrew is an imprint of Elsevier,$$c[2018]
001459432 264_4 $$c2018
001459432 300__ $$a1 online resource (681 pages).
001459432 336__ $$atext$$btxt$$2rdacontent
001459432 337__ $$acomputer$$bc$$2rdamedia
001459432 338__ $$aonline resource$$bcr$$2rdacarrier
001459432 506__ $$aAccess limited to authorized users.
001459432 588__ $$aDescription based on print version record.
001459432 650_0 $$aDrug targeting.
001459432 650_0 $$aNanomedicine.
001459432 655_0 $$aElectronic books
001459432 7001_ $$aGrumezescu, Alexandru Mihai,$$eeditor.
001459432 77608 $$iPrint version:$$tLipid nanocarriers for drug targeting.$$dOxford, United Kingdom ; Cambridge, MA : William Andrew is an imprint of Elsevier, c2018 $$z9780128136874
001459432 852__ $$bebk
001459432 85640 $$3ProQuest Ebook Central Academic Complete $$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=5353696$$zOnline Access
001459432 909CO $$ooai:library.usi.edu:1459432$$pGLOBAL_SET
001459432 980__ $$aBIB
001459432 980__ $$aEBOOK
001459432 982__ $$aEbook
001459432 983__ $$aOnline